Electromyogram Biofeedback in Patients with Fibromyalgia: A Randomized Controlled Trial

Area of Science:

• Pain Management
• Rehabilitation Medicine
• Clinical Trials

Background:

• Electromyogram (EMG) biofeedback is a technique used for chronic pain management.
• Its efficacy in patients diagnosed with fibromyalgia remains uncertain.
• Fibromyalgia is a chronic condition characterized by widespread pain and fatigue.

Purpose of the Study:

• To evaluate the effectiveness of EMG biofeedback as an adjunct therapy for fibromyalgia.
• This randomized controlled trial aimed to assess changes in health status and pain perception.

Main Methods:

• A randomized controlled trial was conducted with patients from a fibromyalgia day care clinic.
• The intervention group received 14 sessions of EMG biofeedback over 8 weeks alongside usual care.
• The control group received usual care alone. Outcomes were measured using the Fibromyalgia Impact Questionnaire (FIQ) and pressure-pain threshold.

Main Results:

• EMG biofeedback did not significantly improve the overall health status of fibromyalgia patients, as measured by the FIQ.
• No significant difference in health status was observed at post-intervention (T1) or 3-month follow-up (T2).
• A significant improvement was noted in the pressure-pain threshold of the trapezius muscles in the EMG biofeedback group.

Conclusions:

• EMG biofeedback therapy does not appear to improve the overall health status of patients with fibromyalgia.
• While localized pain sensitivity may be affected, broader health benefits were not demonstrated.
• Further research may explore specific applications or patient subgroups for EMG biofeedback in fibromyalgia.